Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

APBI makes move into clinical mainstream

Promising data from a variety of ongoing clinical trials has encouraged the American Society for Therapeutic Radiology and Oncology (ASTRO) to publish a consensus statement outlining patient selection criteria and best practices for the use of accelerated partial breast irradiation (APBI). The consensus statement provides guidance to physicians seeking to implement the protocol outside the context of clinical trials The standard of care for breast cancer patients, post-lumpectomy, is whole-breast irradiation (WBI). Typically it takes six to seven weeks, and treats the entire breast along with some underlying ribs, muscles, a crescent of lung, sometimes a bit of heart, and all the skin on the breast. APBI does not treat the entire breast. It focuses on the part of the breast where the tumor was removed. It can be delivered via either brachytherapy or with 3D conformal external radiation beam techniques.

Feature: Cisco, UnitedHealth form reimbursable telehealth network

UnitedHealth Group and Cisco are partnering to build a national telehealth network, which will give patients access to physicians and specialists when in-person visits are not possible. The new Connected Care program combines audio and video technology and health resources to expand physicians' reach into underserved areas. UnitedHealth has committed tens of millions of dollars toward the new initiative.

ASTRO releases consensus statement on accelerated partial breast irradiation

The American Society for Therapeutic Radiolgy and Oncology (ASTRO) has published a consensus statement outlining patient selection criteria and best practices for the use of accelerated partial breast irradiation outside the context of a clinical trial in the July 15 issue of the International Journal of Radiation Oncology*Biology*Physics.

Commonwealth Fund: Public, private insurance would save $265B over ten years

As lawmakers debate how to pay for an overhaul of the U.S. healthcare system, a report from the Commonwealth Fund projects that including both private and public insurance choices in a new insurance exchange would save the United States as much as $265 billion in administrative costs from 2010 to 2020.

Whistleblower accuses EP ablation device makers of kickbacks

A federal judge in Houston has unsealed whistleblower lawsuits alleging that Boston Scientific, Medtronic, St. Jude Medical and four other manufacturers engaged in Medicare fraud -- including illegal kickbacks -- regarding the sale of cardiac surgical ablation devices to treat atrial fibrillation, according to Pioneer Press.

Stroke: Pediatric stroke costs U.S. $42M a year

Stroke in children costs at least $42 million annually in the U.S., researchers reported in this month's edition of Stroke.

FEATURE: Krumholz discusses discrepancy in HF, MI death, readmission rates

In a recent three-year period, 30-day risk-standardized mortality rates for acute MI and heart failure (HF) varied among hospitals and across the country, according to research published online July 9 in Circulation: Cardiovascular Quality and Outcomes.

New radiation oncology organization launched

The Imaging Radiology Oncology Association (IROA) has been formed to represent independent diagnostic testing facilities, radiologists and oncologists.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.